Tenex Clinical Evidence
≥85% Patient Satisfaction1,2
Clinically effective in treating chronic diseased tendons, with patient satisfaction ≥85% in multiple studies. (Results are with the Tenex Health TX System and may vary by patient and anatomy).
Plantar Fasciitis
(KRUSE, CLIN J SPORTS MED 2024)
Patient satisfaction, pain relief, sustained at
1 year, 67 patients
(NAKAGAWA, REGEN MED 2022)
Patient satisfaction, pain relief, sustained at
1 year, 31 patients
(RAZDAN, ET AL 2018)
Patient Satisfaction, Pain relief at 6 months,
would recommend to a friend, 100 patients
Lateral Epicondylitis
(KOH, AM J SPORTS MED 2013)
(SENG AM J SPORTS MED 2016)
(ANG, AM J SPORTS MED 2021)
Patient satisfaction, Pain relief sustained at 7 years, 20 patients
Shoulder
(NAKAGAWA, REGEN MED 2023)
Patient satisfaction, pain relief, sustained at 1 year, 30 patients
Gluteal Tendinopathy
(BAKER, ORTHO J SPORTS MED 2020)
Patient satisfaction, pain relief, sustained at 18 mons, 29 patients
Patellar Tendinopathy
(ELATTRACHE, OPERAT TECH ORTHOP 2013)
Patient satisfaction, pain relief, sustained at 3 mons, 23 patients
Quadriceps, Patellar or Pes Anserine Tendinopathy
(NAEMI, PAIN MED 2024)
Patient satisfaction, pain relief, sustained at 3 mons, 23 patients
Achilles Tendinopathy
(CHIMENTI, J ULTRAS MED 2019)
Patient satisfaction, pain relief, sustained 1-3 years, 34 patients
(FREED, J AM PODIAT MED ASSN)
Patient satisfaction, pain relief, sustained >1 year, 25 patients
Rotator Cuff
(TRIVEDI, J ORTHOP EXP INNOV 2024)
Patient satisfaction, pain relief, sustained at 6 mons, 15 patients
1 All claims cited are from clinical studies with the Tenex Health TX System and not the 2nd Generation System. The Trice Medical Tenex 2nd Generation System incorporates the same fundamental ultrasonic surgical technology as the Tenex Health TX System.
2 Clinical study levels range from expert opinions and demonstrations to prospective, randomized, controlled, cross-over trial. Studies include limitations. A majority of the studies are retrospective case series, looking back and reporting outcomes for patients who underwent treatment with the TX System for the same clinical conditions. Further randomized, controlled trials are recommended.